Question 1

How many shares of CTOR does GEODE CAPITAL MANAGEMENT, LLC own?

Accepted Answer

As of 2026-Q2, GEODE CAPITAL MANAGEMENT, LLC holds 245,407 shares of CTOR (CITIUS ONCOLOGY INC).

Question 2

What is GEODE CAPITAL MANAGEMENT, LLC's CTOR position worth?

Accepted Answer

As of 2026-Q2, GEODE CAPITAL MANAGEMENT, LLC's CTOR position is worth $159,538.

Question 3

Is GEODE CAPITAL MANAGEMENT, LLC buying or selling CTOR?

Accepted Answer

In 2026-Q2, GEODE CAPITAL MANAGEMENT, LLC decreased their CTOR position (-7.3% change in shares).

Question 4

When did GEODE CAPITAL MANAGEMENT, LLC first buy CTOR?

Accepted Answer

Based on available 13F filings, GEODE CAPITAL MANAGEMENT, LLC first reported a position in CTOR in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	245,407	-7.3%	$159,538	0.0%	$0.65	0
2026-Q1	Increased	264,733	+20.3%	$164,107	0.0%	$1.06	18
2025-Q4	Increased	220,047	+31.6%	$220,047	0.0%	$1.05	20
2025-Q3	Increased	167,172	+191.8%	$339,358	0.0%	$2.03	26
2025-Q2	Increased	57,297	+179.0%	$249,241	0.0%	$4.50	25
2025-Q1	Increased	20,539	+62.4%	$19,101	0.0%	$0.67	18
2024-Q4	New	12,651	-	$14,548	0.0%	$1.12	28

CTOR7 quarters

CTOR
7 quarters